Tamoxifen citrate is a salt form of tamoxifen, a nonsteroidal compound widely supplied as an active pharmaceutical ingredient. It is primarily used in pharmaceutical manufacturing and research as a raw material for further processing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 54965-24-1
(Z)-Toremifene
pharmaceutical raw material
Toremifene citrate
pharmaceutical raw material
Levothyroxine sodium
pharmaceutical raw material
Liothyronine sodium
pharmaceutical raw material
Scopolamine hydrochloride
pharmaceutical raw material
(+/-)-norepinephrine hydrochloride
pharmaceutical raw material
(Z)-desethyl methyl tamoxifen
pharmaceutical raw material
CLOMIPHENE CITRATE
pharmaceutical raw material
The international HS code for Tamoxifen citrate (CAS 54965-24-1) is 2922.19.
2922.19
2922 19 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid
FQZYTYWMLGAPFJ-OQKDUQJOSA-N
CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O